Pharmacological functional MRI assessment of the effect of ibuprofen-arginine in painful conditions

International Journal of Immunopathology and Pharmacology

Volumn 23, Issue 3, 2010, Pages 927-935

  Delli Pizzi, Stefano ^a   Mantini, D ^a,b   Ferretti, A ^a   Caulo, M ^a   Salerio, I ^c   Romani, G L ^a   Del Gratta, C ^a   Tartaro, A ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Zambon Group SpA   (Italy)

Author keywords

Arginine; BOLD signal; Ibuprofen; Pain; Pharmacological functional MRI

Indexed keywords

IBUPROFEN ARGININE; PLACEBO; SPIDIFEN; UNCLASSIFIED DRUG;

ADULT; ANALGESIC ACTIVITY; ARTICLE; BRAIN REGION; DRUG EFFECT; ELECTROSTIMULATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; INSULA; MALE; NORMAL HUMAN; OXYGEN BLOOD LEVEL; PAIN; PREMOTOR CORTEX; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; SOMATOSENSORY CORTEX; SOMATOSENSORY STIMULATION;

EID: 78149237413     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300329     Document Type: Article

References (32)

1. Wise RG, Rogers R, Painter D, Bantick S, Ploghaus A, Williams P, Rapeport G, Tracey I. Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil. Neuroimage 2002; 16:999-1014.
2. Salmeron BJ, Stein EA. Pharmacological applications of magnetic resonance imaging. Psychopharmacol Bull 2002; 36:102-29.
3. Wise RG, Williams P, Tracey I. Using fMRI toquantify the time dependence of remifentanil analgesia in the human brain. Neuropsychopharmacology 2004; 29(3):626-35
4. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, Lee L, Isakson P: Pharmacological and Biochemical Demonstration of the Role of Cyclooxygenase-2 in Inflammation and Pain. Proc Natl Acad Sci USA 1994; 91:12013-17.
5. Lawrence KS, Ye FQ, Lewis BK, Frank JA, McLaughlin AC. Measuring the effects of indomethacin on changes in cerebral oxidative metabolism and cerebral blood flow during sensorimotor activation. Magn Reson Med 2003; 50:99-106.
6. Stefanovic B, Bosetti F, Silva AC. Modulatory role of cyclooxygenase-2 in cerebrovascular coupling. Neuroimage 2006; 32:23-32.
7. Baliki M, Katz J, Chialvo DR, Apkarian AV. Single subject pharmacological-MRI (phMRI) study: modulation of brain activity of psoriatic arthritis pain by cyclooxygenase-2 inhibitor. Mol Pain 2005; 1:32.
8. Maihöfner C, Ringler R, Herrndobler F, Koppert W. Brain imaging of analgesic and antihyperalgesic effects of cyclooxygenase inhibition in an experimental human pain model: a functional MRI study. Eur J Neurosci 2007; 26:1344-56.
9. Lorenz IH, Egger K, Schubert H, et al. Lornoxicam characteristically modulates cerebral pain-processing in human volunteers: a functional magnetic resonance imaging study. Br J Anaesth 2008; 100:827-33.
10. Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev 2009; 61:62-97.
11. Kobari M, Fukuuchi Y, Tomita M, Tanahashi N, Takeda H. Role of nitric oxide in regulation of cerebral microvascular tone and autoregulation of cerebral blood flow in cats. Brain Res 1994; 667:255-62.
12. Gally JA, Montague PR, Reeke GN Jr, Edelman GM. The NO hypothesis: possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc Natl Acad Sci USA 1990; 87:3547-51.
13. Sandrini G, Franchini S, Lanfranchi S, Granella F, Manzoni GC, Nappi G. Effectiveness of ibuprofen-arginine in the treatment of acute migraine attacks. Int J Clin Pharmacol Res 1998; 18:145-50.
14. Böger RH, Bode-Böger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol 2001; 41:79-99.
15. Fornasini G, Monti N, Brogin G, et al. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers. Chirality 1997; 9:297-302.
16. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971; 9:97-113.
17. Walker JS, Arroyo JF, Nguyen T, Day RO. Analgesic efficacy of non-steroidal anti-inflammatory drugs in experimental pain in humans. Br J Clin Pharmacol 1993; 36:417-25.
18. Sycha T, Gustorff B, Lehr S, Tanew A, Eichler HG, Schmetterer L. A simple pain model for the evaluation of analgesic effects of NSAIDs in healthy subjects. Br J Clin Pharamcol 2003; 56:165-72.
19. Ferretti A, Del Gratta C, Babiloni C, Caulo M, Arienzo D, Tartaro A, Rossini PM, Romani GL. Functional topography of the secondary somatosensory cortex for nonpainful and painful stimuli: an fMRI study. Neuroimage 2003; 20:1625-38.
20. Mantini D, Caulo M, Ferretti A, Romani GL, Tartaro A. Noxious somatosensory stimulation affects the default-mode of brain function: evidence from functional magnetic resonance imaging. Radiology 2009; 253:797-804.
21. Bartels A, Zeki S. The chronoarchitecture of the cerebral cortex. Philos Trans R Soc Lond B Biol Sci 2005; 360:733-50.
22. McKeown MJ, Makeig S, Brown GG, Jung TP, Kindermann SS, Bell AJ, Sejnowski TJ. Analysis of fMRI data by blind separation into independent spatial components. Hum Brain Mapp 1998; 6:160-88.
23. Hyvärinen A. Fast and robust fixed-point algorithms for independent component analysis. IEEE T Neural Network 1999; 10:626-34.
24. Boynton GM, Engel SA, Glover GH, Heeger DJ. Linear systems analysis of functional magnetic resonance imaging in human V1. J Neurosci 1996; 16:4207-41.
25. Kähkönen S. Magnetoencephalography (MEG): a non-invasive tool for studying cortical effects in psychopharmacology. Int J Neuropsychopharmacol 2006; 9:367-72.
26. Stefanovic B, Schwindt W, Hoehn M, Silva AC. Functional uncoupling of hemodynamic from neuronal response by inhibition of neuronal nitric oxide synthase. J Cereb Blood Flow Metab 2007; 27:741-54.
27. Ferretti A, Babiloni C, Gratta CD, Caulo M, Tartaro A, Bonomo L, Rossini PM, Romani GL. Functional topography of the secondary somatosensory cortex for nonpainful and painful stimulation of median and tibial nerve: an fMRI study. Neuroimage 2004; 23:1217-25.
28. Wager TD, Rilling JK, Smith EE, et al. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 2004; 303:1162-7.
29. Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK. Neurobiological Mechanisms of the placebo effect. J Neurosci 2005; 25:390-402.
30. Peyron R, Laurent B, García-Larrea L. Functional imaging of brain responses to pain. A review and meta-analysis. Neurophysiol Clin 2000; 30(5):263-88.
31. Ingvar M. Pain and functional imaging. Philos Trans R Soc Lond B Biol Sci 1999; 354:1347-58.
32. Morikawa E, Moskowitz MA, Huang, Z, Yoshida T, Irikura K, Dalkara T. L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke 1994; 25:429-35.